227
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Influence of the Size of Micronized Active Pharmaceutical Ingredient on the Aerodynamic Particle Size and Stability of a Metered Dose Inhaler

, Ph.D., , B.A., , Ph.D., , M.S., , M.S., , Ph.D. & , Ph.D. show all
Pages 705-714 | Published online: 09 Aug 2004

References

  • Dolovich M. Characterization of medical aerosols: physical and clinical requirements for new inhalers. Aerosol Sci. Tech. 1995; 22: 392–399
  • Elvecrog J. Metered dose inhalers in a CFC‐free future. Pharm. Tech. Eur. 1997; 9(1)52–55
  • Keller M. Innovations and perspectives of metered dose inhalers in pulmonary drug delivery. Int. J. Pharm. 1999; 186: 81–90, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Dolovich M. B., Ruffin R. E., Roberts R., Newhouse M. T. Optimal delivery of aerosols from metered dose inhalers. Chest 1981; 80(Suppl.)911–915, [PUBMED], [INFOTRIEVE]
  • Meyer K. C., Auerbach W., Auerbach R. Drug delivery to the lung. Polymeric Site‐Specific Pharmacotherapy, A. J. Domb. John Wiley and Sons, New York 1994; 347–367
  • Pritchard J. N. The influence of lung deposition on clinical response. J. Aerosol Med. 2001; 14(1)S19–S26, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Leach C. L., Davidson P. J., Boudreau R. J. Improved airway targeting with the CFC‐free HFA‐beclomethasone metered‐dose inhaler compared with CFC‐beclomethasone. Eur. Respir. J. 1998; 12: 1346–1353, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Dunbar C. A. Atomization mechanisms of the pressurized metered dose inhaler. Part. Sci. Technol. 1998; 15(3–4)253–271
  • Berry J., Heimbecher S., Hart J. L., Sequeira J. Influence of the metering chamber volume and actuator design on the aerodynamic particle size of a suspension metered dose inhaler. Drug Dev. Ind. Pharm. 2003; 29(8)865–876, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Sequeira J., Berry J., Sharpe S., Naini V., Hart J. A comparison of metered dose inhaler particle size distribution by Andersen cascade impaction using two types of entry ports. Respir. Drug Deliv. VIII 2002; 2: 573–576
  • Careless J. E., Moustafa M. A., Rapson H. D.C. Effect of crystal form, cortisone alcohol and agitation on crystal growth of cortisone acetate in aqueous suspensions. J. Pharm. Pharmacol. 1968; 20(8)639–645
  • Wey J. S., Strong R. W. Influence of the Gibbs–Thomson effect on the growth behavior of AgBr crystals. Photogr. Sci. Eng. 1977; 21(5)248–252
  • Garside J., Davey R. J. Secondary contact nucleation: kinetics, growth and scale‐up. Chem. Eng. Commun. 1980; 4: 393–424
  • Stávek J., Ulrich J. A possible new approach to the better understanding of crystallization kinetics. Cryst. Res. Technol. 1994; 29(4)465–484
  • Tzou T. Z., Pachuta R. R., Coy R. B., Schultz R. K. Drug form selection in albuterol‐containing metered‐dose inhaler formulations and its impact on chemical and physical stability. J. Pharm. Sci. 1997; 86(12)1352–1357, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Noboru S., Masaaki Y., Akira S., Noriaki K. Growth enhancement and liquid‐inclusion formation by contacts on NaCl crystal. AIChE J. 1999; 45(5)1153–1156, [CROSSREF]
  • Kim K. S., Kim J. K., Kim W. S. Silica particle growth in metastable supersaturation solution. J. Mater. Res. 2001; 16(2)545–552
  • Mullin J. W. Crystallization4th Ed. Butterworth, London 2001, pp. 216‐288; 181‐214
  • Matthys H. Chlorofluorocarbon‐free aerosol therapy in patients with pulmonary airflow obstruction. Respiration 1996; 63(3)321–324, [PUBMED], [INFOTRIEVE]
  • Byron P. R., Miller N. C., Blondino F. E., Visich J. E., Ward G. H. Some aspects of alternative propellant solvency. Respir. Drug Deliv. IV 1994; 239–242
  • Vervaet C., Byron P. R. Drug‐surfactant‐propellant interactions in HFA‐formulations. Int. J. Pharm. 1999; 186: 13–30, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Cummings R. H. Pressurized metered dose inhalers: chlorofluorocarbon to hydrofluoroalkane transition‐valve performance. J. Allergy Clin. Immunol. 1999; S230–S235
  • McDonald K. J., Martin G. P. Transition to CFC‐free metered dose inhalers—into the new millennium. Int. J. Pharm. 2000; 201: 89–107, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Hixon L. M. Select an effective size‐reduction system. Chem. Eng. Prog. 1991; 87(5)36–44
  • Miranda S., Yaeger S. Homing in on the best size reduction method. Chem. Eng. 1998; 105(12)102–110
  • Miranda S. Advances in powder micronization technology for the pharmaceutical industry. J. Pharm. Proc. 1997; 18, Nov Sup
  • Akbarieh M., Tawashi R. Morphic features of solid particles after micronization in the fluid energy mill. Int. J. Pharm. 1987; 35: 81–89, [CROSSREF]
  • Milosovich S. Particle size determination via cascade impaction. Pharm. Technol. 1992; 16: 82–86
  • Johnsen M. A. Properties of aerosol particles. Spray Technol. Mark. 1992; 2(8)46–55
  • General Chapter 601. United States Pharmacopeia 2001; 25: 1969–1980
  • Careless J. E. A study into the prediction of mass transfer. J. Pharm. Pharmacol. 1976; 28(8)2
  • Ziller K. H., Rupprecht H. Control of crystal growth in drug suspensions. Pharm. Technol. Drug Stab. 1989; 118–131
  • White E. T., Bendig L. L., Larson M. A. The effect of size on the growth rate of potassium sulfate crystals. AIChE Symp. Ser. 1976; 153(72)41–47
  • Yushan R., Qiu T., Yuanmou Z. A study on the growth kinetics of small crystals of KCl. Process Technol. Proc. 1984; 2: 289–292, (Ind. Crystallization)
  • Jones A. G., Budz J., Mullin J. W. Crystallization kinetics of potassium sulfate in an MSMPR agitated vessel. AIChE J. 1986; 32(12)2002–2009, [CROSSREF]
  • Combes C., Freche M., Rey C. Nucleation and crystal growth of dicalcium phosphate dihydrate on titanium powder. J. Mater. Sci., Mater. Med. 1995; 6(12)699–702, [CROSSREF]
  • Phillips E. M., Byron P. R., Dalby R. N. Axial ratio measurements for early detection of crystal growth in suspension‐type metered dose inhalers. Pharm. Res. 1993; 10(3)454–456, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Ravin L. J., Shami E. G., Rattie E. S. Physical‐chemical evaluation of 3‐(3‐hydroxy‐3‐methylbutylamino)‐5‐methyl‐as, Triazino [5,6‐b] Indole. J. Pharm. Sci. 1970; 59(9)1290–1295, [PUBMED], [INFOTRIEVE]
  • Haleblian J. K. Characterization of habits and crystalline modification of solids and their pharmaceutical applications. J. Pharm. Sci. 1975; 64(8)1269–1288, [PUBMED], [INFOTRIEVE]
  • Ward G. H., Schultz R. K. Process‐induced crystallinity changes in albuterol sulfate and its effect on powder physical stability. Pharm. Res. 1995; 12(5)773–779, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Auer S., Frenkel D. Suppression of crystal nucleation in polydisperse colloids due to increase of the surface free energy. Nature 2001; 413(6857)711–713, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Verdoes D., Kashchiev D., van Rosmalen G. M. Determination of nucleation and growth rates from induction times in seeded and unseeded precipitation of calcium carbonate. J. Cryst. Growth 1992; 118(N3–4)401–413, [CROSSREF]
  • Berry J., Kline L. C., Naini V., Chaudhry S., Hart J. L., Sequeira J. Influence of the valve lubricant on the aerodynamic particle size of a suspension metered dose inhaler, Manuscript submitted for publication

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.